Because GLP-1 agonists seem to reduce patients’ desire for food, it isn’t surprising that they might also shrink or even ...

A new interactive budget tool from Levity helps users see whether GLP-1 medications fit into their real-world finances.

COLUMBUS, Ohio -- Former Ohio State football player Demario McCall was sentenced to 7 to 10 years in prion after pleading ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Doctors called it “huge for patients,” if true. Patients who’ve struggled to afford the pricey medicines shared hope the price could be reached. Stocks of Novo Nordisk and Eli Lilly fell significantly ...

Incentivizing innovation requires the protection of intellectual property rights. Allowing compounded pharmacies to sell ...

An alliance of scientists at the Broad Institute and Bayer Pharmaceuticals have developed a drug candidate, sevabertinib, ...

Shares of Hims & Hers Health are trading lower Friday morning after comments from President Donald Trump indicated that he ...

Alex Parker sits down with Leigh Verbois, Board Member of the Alliance for Safe Online Pharmacies and former FDA official, to ...

Plants are consummate chemists, using the sun's energy and carbon dioxide from the air, to conjure a dazzling array of ...

Leading makers of GLP-1 (Glucagon-Like Peptide-1) weight loss drugs like Ozempic and Zepbound are facing off against domestic compounding pharmacies that import foreign ingredients and make cheaper, ...